Écrit par ibidi GmbH | 26 Juin 2014

(PresseBox) (Germany, Munich, 26.06.2014 ) German biotechnology company, ibidi GmbH, offers an introductory discount on Fuse-It reagents, a new alternative to gene transfection. This novel product line uses membrane fusion as a highly superior method of transferring various molecules and particles into living cells. The speed and efficiency of this technique cuts down experiment times from...

Écrit par Wiley | 10 Juin 2014

People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients’ risk of dying from their disease. The findings, which are published in BJU International, indicate that cholesterol testing may help doctors as they monitor and treat patients with kidney cancer.

Increasing evidence suggests...

Écrit par Wiley | 29 Mai 2014

Circumcision is performed for various reasons, including those that are based on religion, aesthetics, or health. New research indicates that the procedure may help prevent prostate cancer in some men. The findings, which are published in BJU International, add to a growing list of advantages to circumcision.

Besides advanced age, African ancestry, and family history of prostate cancer, no...

Écrit par GlobalData | 21 Mai 2014

LONDON, UK (GlobalData), 20 May 2014 - As one of the fastest emerging areas of in vitro diagnostic devices, the companion diagnostics testing market value will increase from $421 million in 2013 to $669.7 million by 2020, at a Compound Annual Growth Rate (CAGR) of 6.85%, says research and consulting firm GlobalData.

According to the company’s latest report*, the major feature of the...